Resveratrol Butyrate Esters Inhibit Obesity Caused by Perinatal Exposure to Bisphenol A in Female Offspring Rats

Molecules. 2021 Jun 30;26(13):4010. doi: 10.3390/molecules26134010.

Abstract

Resveratrol butyrate esters (RBE) are derivatives of resveratrol (RSV) and butyric acid and exhibit biological activity similar to that of RSV but with higher bioavailability. The aim of this study was designed as an animal experiment to explore the effects of RBE on the serum biochemistry, and fat deposits in the offspring rats exposed to bisphenol A (BPA), along with the growth and decline of gut microbiota. We constructed an animal model of perinatal Bisphenol A (BPA) exposure to observe the effects of RBE supplementation on obesity, blood lipids, and intestinal microbiota in female offspring rats. Perinatal exposure to BPA led to weight gain, lipid accumulation, high levels of blood lipids, and deterioration of intestinal microbiota in female offspring rats. RBE supplementation reduced the weight gain and lipid accumulation caused by BPA, optimised the levels of blood lipids, significantly reduced the Firmicutes/Bacteroidetes (F/B) ratio, and increased and decreased the abundance of S24-7 and Lactobacillus, respectively. The analysis of faecal short-chain fatty acid (SCFA) levels revealed that BPA exposure increased the faecal concentration of acetate, which could be reduced via RBE supplementation. However, the faecal concentrations of propionate and butyrate were not only significantly lower than that of acetate, but also did not significantly change in response to BPA exposure or RBE supplementation. Hence, RBE can suppress BPA-induced obesity in female offspring rats, and it demonstrates excellent modulatory activity on intestinal microbiota, with potential applications in perinatological research.

Keywords: Firmicutes/Bacteroidetes (F/B) ratio; bisphenol A (BPA); obesity; perinatal exposure; resveratrol butyrate esters (RBEs).

MeSH terms

  • Animals
  • Benzhydryl Compounds / toxicity*
  • Butyric Acid / pharmacology*
  • Fatty Acids, Volatile / metabolism
  • Female
  • Gastrointestinal Microbiome / drug effects
  • Obesity* / chemically induced
  • Obesity* / drug therapy
  • Obesity* / metabolism
  • Phenols / toxicity*
  • Pregnancy
  • Prenatal Exposure Delayed Effects* / chemically induced
  • Prenatal Exposure Delayed Effects* / drug therapy
  • Prenatal Exposure Delayed Effects* / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Resveratrol / pharmacology*

Substances

  • Benzhydryl Compounds
  • Fatty Acids, Volatile
  • Phenols
  • Butyric Acid
  • bisphenol A
  • Resveratrol